← Open Payments lookup

GRAHAM MITCHELL: Open Payments

NPI 1346419736 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,792 in 185 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $3,252 · 2025 $3,792

Food & beverage: $3,792
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.27$537
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$442
ABBVIE INC.24$396
Axsome Therapeutics, Inc.16$359
Alkermes, Inc.13$334
Vanda Pharmaceuticals Inc.14$285
Lundbeck LLC16$255
Janssen Pharmaceuticals, Inc10$247
Teva Pharmaceuticals USA, Inc.11$236
Supernus Pharmaceuticals, Inc.11$217

Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, ARISTADA, Qelbree, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.